# Trending Content OS — Daily Run
**Date:** 2026-08-27 | **Niche:** Health & Wellness

---

## 1. Preflight Summary

| Check | Status |
|---|---|
| All 7 configs + CLAUDE.md loaded | ✅ |
| `site_niche` / `target_audience` set | ✅ |
| `site_url` | ⚠️ Not configured — self-check skipped; competitor-list fallback used for duplicate/SERP-gap context |
| Google Trends | ✅ Available via injected SerpAPI pre-fetch (`search_velocity_source: google_trends`) |
| Google News Radar | ✅ Injected (144 unique headlines / 12 queries) |
| Deferred topics (`data/deferred_topics.yaml`) | None past `recheck_on` today |
| Recurring themes (2+ consecutive runs) | Food recall surge, wellness-industry skepticism, measles outbreak — all recurring; watched for staleness below |
| `next_action` | `run_signal_listener` |

---

## 2. Google News Radar Coverage Summary

Main clusters identified across the 144-headline radar pull:

| Cluster | Disposition | Reason |
|---|---|---|
| **Measles outbreak (PA deaths, [Maryland 3-county outbreak](https://health.maryland.gov/newsroom/Pages/Maryland%20Department%20of%20Health%20declares%20measles%20outbreak%20in%20three%20Maryland%20counties.aspx), [CDC data page](https://www.cdc.gov/measles/data-research/index.html))** | Rejected — existing | Covered 8/25–8/26; no new case count/agency action today |
| **Celebrity health (Dolly Parton, Phil Collins, Tim Curry)** | Rejected — off-category | Excluded per `brand_safety_rules.allow_celebrity_gossip: false`, despite Google Trends breakout velocity |
| **FDA recall wave** — [thyroid tablets](https://thehill.com/policy/healthcare/6049169-thyroid-tablets-recalled-nationwide-potential-superpotency-fda/)/[levothyroxine](https://medshadow.org/drug-updates-recalls/fda-recalls-and-warnings/subpotent-levothyroxine-sodium-tablets-superpotent-thyroid-tablets/), [Baxter IV bags](https://www.ktalnews.com/health/baxter-sodium-chloride-recall/), [eye drops](https://www.nytimes.com/2026/08/23/health/clear-eyes-eye-drops-fda-recall.html), [blueberries](https://www.washingtonpost.com/health/2026/08/20/fda-upgrades-recall-frozen-berries-highest-risk-warning/), [sprouts](https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-shiga-toxin-producing-e-coli-salmonella-sprouts-august-2026) | **Split** | Levothyroxine = **retained (new)**; Baxter = **rejected at Gate 02b** (single local-outlet source, breaking-recall exception not met); eye drops/blueberries/sprouts = existing duplicates |
| **Cyclospora outbreak escalation** (Trending Now: "confirmed cyclosporiasis cases 48 states," [CDC](https://www.cdc.gov/)) | **Retained — update** | New scale development (48-state spread) vs. 8/22 lettuce-sourcing coverage |
| **Diet science** — [WashU low-carb/liver study](https://medicine.washu.edu/news/low-carb-diet-delivers-added-liver-benefits-beyond-weight-loss/) / [Scientific American keto-vs-Mediterranean trial](https://www.scientificamerican.com/article/is-the-keto-diet-better-than-the-mediterranean-new-clinical-trial-reveals-health-benefits/) | **Retained — new** | Confirmed by direct Google Trends rising query match |
| **Brain/aging research** — [Nature Medicine oligodendrocyte study](https://www.nature.com/articles/s41591-026-04608-y) | **Retained — new** | Single-source but tier-1 journal |
| **Wellness-industry critique/regulation** (AMA wearables, [Topol/Cohen substack](https://erictopol.substack.com/p/deborah-cohen-the-wellness-industrial), NYT "Spa Weekend," UCLA wellness drink) | **Split** | AMA regulatory angle = **retained (new)**; wellness-drink/pseudoscience-critique threads = existing duplicates (8/25–8/26) |
| **GLP-1 / Zepbound cost study** (Lilly-funded, [PR Newswire](https://www.prnewswire.com/news-releases/zepbound-linked-to-lower-healthcare-costs-in-adults-over-age-55-with-obesity-according-to-a-real-world-study-302859960.html)) | Monitored | Below trend-strength threshold; industry-funded sourcing flagged |
| **NFL CTE "bombshell" study** ([Yahoo Sports](https://sports.yahoo.com/articles/terrifying-nfl-discovery-bombshell-medical-152045510.html)) | Rejected at Gate 02b | Sensationalized single-outlet framing, no named journal/institution |
| **Clinical trial explainers** (CNN, Cancer Health) | Rejected — existing | Duplicate of 8/25 "what to know before joining a clinical trial" |
| **Political/policy-adjacent** (UW research funding cuts, immigration/healthcare study) | Rejected — brand safety | `allow_politics: false` |
| **Local/business/B2B** (Raiders donation, Clemson sponsorship, Arkansas rural health funds, UnityPoint lawsuit, FBI Detroit probe, MedTech Dive wearables-in-trials, Perelel supplement trial) | Rejected — off-category / low audience relevance | Local news, pure business, or supplement marketing exclusions |

---

## 3. Signal Summary

```yaml
signal_summary:
  run_started_at: "2026-08-27T00:00:00Z"
  total_signals_reviewed: 144
  total_signals_retained: 5
  total_rejected: 139
  google_trends_available: true
  search_velocity_source: "google_trends"
  rejection_breakdown:
    off_category: 21
    brand_safety: 4
    duplicate: 9
    weak_signal: 8
    unverified_claim: 2
    other: 95   # local/business/B2B/low-relevance not itemized individually
  highest_priority_topic: "Keto vs. Mediterranean diet clinical trial (WashU Medicine)"
  strongest_signal_source: "Google Trends direct query match + WashU Medicine institutional release"
  tools_unavailable: []
  notes: "Recurring themes flagged: food recall surge (4th consecutive appearance — treat future individual recalls as updates, not new stories, unless casualty/scale changes), wellness-industry skepticism (3rd appearance), measles outbreak (3rd appearance, still no new casualty data today). Baxter IV bag recall is likely real but under-sourced in this run's radar pull — recommend recheck within 24–48h rather than permanent rejection."
```

---

## 4. Skill 02b — Health Claim Verification Gate: Routing Summary

| Topic | Risk Type | Primary Source | Gate Result | Notes |
|---|---|---|---|---|
| Levothyroxine nationwide recall | recall | FDA notice (via The Hill/MedShadow) | **Pass** | 2 named outlets + FDA-sourced claim |
| Cyclospora 48-state escalation | outbreak data (not gate-triggering type) | CDC.gov | **Not applicable** | Tier-1 direct, gate not required for outbreak case-count signal type |
| WashU/SciAm keto-vs-Mediterranean trial | clinical_trial | WashU Medicine institutional release | **Pass** | Corroborated by Scientific American + direct Trends query |
| Nature Medicine oligodendrocyte study | study_or_research | Nature Medicine (DOI) | **Pass** | Single-source; confidence capped low downstream |
| Baxter IV bag fiberglass recall | recall | None directly retrieved | **Reject** | Breaking-recall exception not met (only 1 local outlet; needs 3+ incl. FDA/AP/Reuters) |
| Zepbound/GLP-1 healthcare-cost study | drug_or_treatment_claim | Manufacturer statement (Lilly, via PR Newswire) | **Pass w/ flag** | No independent/peer-reviewed corroboration; industry-funded — routed to Monitor on trend-score fail, not gate fail |
| NFL CTE "bombshell" study | study_or_research | None named | **Reject** | Single non-trusted outlet, sensationalized framing, no journal/institution cited |

---

## 5. Final Editorial Priority Board

| Priority | Topic | Publish Timing | Trend | Opportunity | Discover | Urgency | Confidence |
|---|---|---|---|---|---|---|---|
| **P1** | Keto vs. Mediterranean diet trial (WashU) | immediate | 71 | 84 | 5 | today | high |
| **P1** | Cyclospora outbreak — 48-state escalation | immediate | 78 | 81 | 4 | today | medium |
| **P2** | Levothyroxine nationwide recall | short_term | 57 | 80 | 4 | today | medium |
| **P3** | Nature Medicine oligodendrocyte/cognitive decline study | scheduled | 50 | 78 | 4 | this_week | low |
| **P4** | AMA: rethink wellness app/wearable regulation | evergreen | 50 | 64 | 3 | this_week | low |

---

## 6. Editorial Briefs

### P1 — Keto vs. Mediterranean Diet: WashU Trial Reveals Liver Benefits
```yaml
priority_level: P1
publish_timing: immediate
topic: "Low-carb/keto diet shows added liver benefits beyond weight loss vs. Mediterranean diet, WashU trial finds"
primary_entity: "WashU Medicine low-carb vs. Mediterranean diet clinical trial"
signal_type: clinical_trial
allowed_category: "nutrition and diet science"
trend_strength_score: 71
opportunity_score: 84
discover_score: 5
urgency: today
confidence: high
content_status: new
source_count: 3
recommended_angle: "Go beyond 'which diet wins' — explain the specific liver-metabolism mechanism WashU identified that Mediterranean-diet coverage has missed, positioning it as evidence-based nuance rather than diet-war clickbait."
why_now: "Direct Google Trends rising-query match ('washu medicine keto mediterranean diet study') plus same-day dual coverage from WashU Medicine and Scientific American — high, current search demand with a genuine primary-source study."
primary_headline: "A New Clinical Trial Says Low-Carb Diets Beat Mediterranean for Liver Health — Here's the Catch"
next_steps: "Assign to writer with nutrition-science background; pull WashU press release for named researchers/journal; add RDN comment per expert_sources.yaml on generalizability."
notes: "Sources: [WashU Medicine](https://medicine.washu.edu/news/low-carb-diet-delivers-added-liver-benefits-beyond-weight-loss/), [Scientific American](https://www.scientificamerican.com/article/is-the-keto-diet-better-than-the-mediterranean-new-clinical-trial-reveals-health-benefits/). ⚠️ Integrity note: confirm trial design (RCT vs. observational) and sample size before framing as definitive — avoid overstating generalizability of a single trial."
```

### P1 — Cyclospora Outbreak Escalates to 48 States
```yaml
priority_level: P1
publish_timing: immediate
topic: "Cyclospora outbreak confirmed across 48 states — what's changed since the lettuce recall"
primary_entity: "Cyclospora cayetanensis outbreak (CDC surveillance)"
signal_type: breaking_news
allowed_category: "infectious disease"
trend_strength_score: 78
opportunity_score: 81
discover_score: 4
urgency: today
confidence: medium
content_status: update
source_count: 2
recommended_angle: "Update the produce-source narrative (previously iceberg lettuce, 8/22) with the new national-scale data — answer 'has this spread beyond the original source?' directly, since CDC case data now shows near-nationwide reach."
why_now: "Real-time Google Trends breakout term ('confirmed cyclosporiasis cases 48 states') directly tied to CDC case-data page — a genuine scale escalation since our 8/22 lettuce-linked coverage, not a repeat of the same story."
primary_headline: "Cyclospora Cases Now Confirmed in 48 States — Here's What's Different From the Lettuce Recall"
next_steps: "Confirm exact CDC case count and state list before publishing; verify whether source has been narrowed further or remains under investigation."
notes: "Source: CDC Cyclosporiasis Case Data page (cdc.gov) [exact URL unverified in this run's radar pull — confirm via cdc.gov/parasites/cyclosporiasis before publishing]. Confidence held at medium pending a second independent outlet confirming the 48-state figure."
```

### P2 — Levothyroxine Nationwide Recall
```yaml
priority_level: P2
publish_timing: short_term
topic: "FDA recall: nationwide levothyroxine (thyroid) tablets over 'superpotency' risk"
primary_entity: "Levothyroxine sodium tablets recall (FDA, August 2026)"
signal_type: recall
allowed_category: "FDA and CDC regulatory updates"
trend_strength_score: 57
opportunity_score: 80
discover_score: 4
urgency: today
confidence: medium
content_status: new
source_count: 3
recommended_angle: "Practical patient-action piece: how to check if your prescription is affected, what 'superpotency' means clinically, and symptoms of thyroid-hormone overdose to watch for — service journalism, not just recall notice repetition."
why_now: "New nationwide FDA recall (distinct from the 8/21 bladder-medication recall) affecting a widely prescribed chronic-disease drug; passed Gate 02b via FDA-sourced coverage."
primary_headline: "FDA Recalls Thyroid Medication Nationwide Over Potency Concerns — What Patients Should Do Now"
next_steps: "Pull exact FDA recall notice/lot numbers before publishing; add endocrinologist or pharmacist quote on symptoms of levothyroxine overcorrection."
notes: "Sources: [The Hill](https://thehill.com/policy/healthcare/6049169-thyroid-tablets-recalled-nationwide-potential-superpotency-fda/), [MedShadow Foundation](https://medshadow.org/drug-updates-recalls/fda-recalls-and-warnings/subpotent-levothyroxine-sodium-tablets-superpotent-thyroid-tablets/). Distinct from prior bladder-medication recall (8/21) — confirm no overlap before publishing."
```

### P3 — Nature Medicine: Oligodendrocyte Dysfunction & Cognitive Decline
```yaml
priority_level: P3
publish_timing: scheduled
topic: "New Nature Medicine study links oligodendrocyte dysfunction to age-related cognitive decline"
primary_entity: "Oligodendrocyte dysfunction (Nature Medicine study)"
signal_type: study_or_research
allowed_category: "aging and longevity"
trend_strength_score: 50
opportunity_score: 78
discover_score: 4
urgency: this_week
confidence: low
content_status: new
source_count: 1
recommended_angle: "Explain the mechanism in plain language ('what oligodendrocytes are and why brain aging researchers are watching them') — a clear explanatory gap since this is dense, single-source science journalism territory."
why_now: "Fresh, peer-reviewed Nature Medicine publication (DOI available); no other outlet has covered it yet — genuine SERP whitespace."
primary_headline: "Scientists Just Found a New Culprit Behind Age-Related Brain Decline"
next_steps: "Seek independent neuroscientist/geriatrician comment before publishing, given single-source status; do not generalize beyond study population."
notes: "Source: [Nature Medicine](https://www.nature.com/articles/s41591-026-04608-y). ⚠️ Integrity note: single-source coverage — confidence held at low until independent expert or secondary outlet corroborates; avoid causation language beyond what the study supports."
```

### P4 — AMA: Regulate Wellness Apps and Wearables
```yaml
priority_level: P4
publish_timing: evergreen
topic: "AMA says it's time to rethink regulation of wellness apps and wearable devices"
primary_entity: "American Medical Association (AMA) wellness-tech regulation statement"
signal_type: policy_or_regulatory_change
allowed_category: "public health and epidemiology"
trend_strength_score: 50
opportunity_score: 64
discover_score: 3
urgency: this_week
confidence: low
content_status: new
source_count: 1
recommended_angle: "Consumer-facing explainer: what's actually regulated vs. unregulated in the wellness-wearable space (e.g., FDA-cleared devices vs. consumer trackers), using AMA's statement as the news hook."
why_now: "Ties into a live 'wellness-industrial complex' critique thread (Topol/Cohen, 8/23) but adds a concrete regulatory angle not yet covered."
primary_headline: "The AMA Wants Wellness Apps Regulated Like Medical Devices — Here's Why"
next_steps: "Confirm AMA statement's scope (policy resolution vs. opinion piece) before drafting; treat as evergreen/backlog given trend score sits at threshold on estimated velocity."
notes: "Source: [AMA](https://www.ama-assn.org/practice-management/digital-health/it-s-time-rethink-how-wellness-apps-devices-are-regulated). trend_strength_score estimated partly from broad 'wellness' category search interest (Trends latest=63) rather than a direct query match — confidence held low; SERP difficulty and format to be confirmed before moving up in queue."
```

---

## 7. Rejected Topics Log

| Topic | Reason |
|---|---|
| Dolly Parton / Phil Collins / Tim Curry health updates | Off-category — celebrity health (`allow_celebrity_gossip: false`), despite Trends breakout |
| Measles outbreak (PA/Maryland) | Existing — covered 8/25–8/26, no new development today |
| Sprouts E. coli/Salmonella, eye drops recall, frozen blueberries recall | Existing — duplicates of 8/20–8/25 coverage |
| Clinical trial explainers (CNN, Cancer Health) | Existing — duplicate of 8/25 "what to know before joining a trial" |
| Wellness drink (UCLA), wellness-pseudoscience critique | Existing — duplicates of 8/25–8/26 |
| Baxter IV bag fiberglass recall | **Gate 02b reject** — single local-news source; breaking-recall exception not met |
| NFL CTE "bombshell" study | **Gate 02b reject** — sensationalized, single non-trusted outlet, no named primary source |
| Zepbound/GLP-1 healthcare-cost study | Trend score below threshold (42); industry-funded, no independent verification — monitor only |
| NYU Langone ketamine trial (launch) | Trend score below threshold (48.5) — early-stage trial announcement, revisit when results emerge |
| Wellness stacking (habit psychology) | Trend score below threshold (38) — thin sourcing (1 outlet) |
| Robotic knee replacement trial | Insufficient primary-source detail (no named journal) — monitor |
| Immigration policy/healthcare study, UW research funding cuts | Brand safety — political drift (`allow_politics: false`) |
| Perelel women's-health protein trial | Excluded category — supplement/product marketing |
| MedTech Dive wearables-in-trials guidance | Low audience relevance — B2B/industry niche |
| Local/business items (Raiders donation, Clemson, Arkansas rural funding, UnityPoint lawsuit, FBI Detroit probe, court-ordered MH care Baltimore, NASA moon base, wellness retreat real estate, student/veteran wellness centers) | Off-category — local news / pure business exclusions |
| Ice cream recall (rubber contamination) | Low priority — folded into existing recall-surge coverage (8/24 explainer) |

---

## 8. Integrity Flags (Consolidated)

⚠️ **WashU diet trial**: Confirm RCT vs. observational design and sample size before framing findings as definitive.
⚠️ **Cyclospora update**: Verify exact CDC case count/state list directly before publishing; source URL unverified in this run.
⚠️ **Nature Medicine oligodendrocyte study**: Single-source coverage — seek independent expert corroboration; avoid causation overreach.
⚠️ **Zepbound/GLP-1 cost study** (monitored, not briefed): Manufacturer-funded real-world study with no independent/peer-reviewed backing — do not brief without journal-level corroboration.
⚠️ **Baxter IV bag recall** (rejected): Likely legitimate but under-sourced this run — recommend active recheck within 24–48h rather than permanent dismissal.

---

## 9. Run Notes

- `site_url` not configured — all duplicate/SERP-gap checks used competitor-list fallback (`configs/competitor_list.yaml`) per Skill 01/08 fallback rules.
- Recurring-theme watch: food recalls (4th consecutive run), wellness-industry skepticism (3rd), measles outbreak (3rd) — recommend confirming these aren't producing diminishing-return coverage.
- Baxter IV bag recall added to recommendation for `data/deferred_topics.yaml` with `recheck_on: 2026-08-29` given likely legitimacy but current under-sourcing.
- No tool outages this run; Google Trends and Google News Radar both fully available.
- Dashboard and `data/run_history.yaml` update assumed handled by `run_pipeline.py` post-processing per Daily Run Step 6–9.